205 related articles for article (PubMed ID: 29391903)
1. Efficacy of a ketogenic diet with concomitant intranasal perillyl alcohol as a novel strategy for the therapy of recurrent glioblastoma.
Santos JG; Da Cruz WMS; Schönthal AH; Salazar MD; Fontes CAP; Quirico-Santos T; Da Fonseca CO
Oncol Lett; 2018 Jan; 15(1):1263-1270. PubMed ID: 29391903
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant effect of low-carbohydrate diet on outcomes of patients with recurrent glioblastoma under intranasal perillyl alcohol therapy.
Santos JG; Faria G; Cruz WDCSD; Fontes CA; Schönthal AH; Quirico-Santos T; da Fonseca CO
Surg Neurol Int; 2020; 11():389. PubMed ID: 33282452
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of monoterpene perillyl alcohol upon survival rate of patients with recurrent glioblastoma.
da Fonseca CO; Simão M; Lins IR; Caetano RO; Futuro D; Quirico-Santos T
J Cancer Res Clin Oncol; 2011 Feb; 137(2):287-93. PubMed ID: 20401670
[TBL] [Abstract][Full Text] [Related]
4. Ras pathway activation in gliomas: a strategic target for intranasal administration of perillyl alcohol.
da Fonseca CO; Linden R; Futuro D; Gattass CR; Quirico-Santos T
Arch Immunol Ther Exp (Warsz); 2008; 56(4):267-76. PubMed ID: 18726148
[TBL] [Abstract][Full Text] [Related]
5. Preliminary results from a phase I/II study of perillyl alcohol intranasal administration in adults with recurrent malignant gliomas.
da Fonseca CO; Schwartsmann G; Fischer J; Nagel J; Futuro D; Quirico-Santos T; Gattass CR
Surg Neurol; 2008 Sep; 70(3):259-66; discussion 266-7. PubMed ID: 18295834
[TBL] [Abstract][Full Text] [Related]
6. Phase I trial of intranasal NEO100, highly purified perillyl alcohol, in adult patients with recurrent glioblastoma.
Schönthal AH; Peereboom DM; Wagle N; Lai R; Mathew AJ; Hurth KM; Simmon VF; Howard SP; Taylor LP; Chow F; da Fonseca CO; Chen TC
Neurooncol Adv; 2021; 3(1):vdab005. PubMed ID: 33604574
[TBL] [Abstract][Full Text] [Related]
7. Perillyl alcohol: Dynamic interactions with the lipid bilayer and implications for long-term inhalational chemotherapy for gliomas.
da Fonseca CO; Khandelia H; Salazar MD; Schönthal AH; Meireles OC; Quirico-Santos T
Surg Neurol Int; 2016; 7():1. PubMed ID: 26862440
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome in patients with recurrent malignant glioma treated with Perillyl alcohol inhalation.
DA Fonseca CO; Teixeira RM; Silva JC; DE Saldanha DA Gama Fischer J; Meirelles OC; Landeiro JA; Quirico-Santos T
Anticancer Res; 2013 Dec; 33(12):5625-31. PubMed ID: 24324108
[TBL] [Abstract][Full Text] [Related]
9. Preclinical development and clinical use of perillyl alcohol for chemoprevention and cancer therapy.
Chen TC; Fonseca CO; Schönthal AH
Am J Cancer Res; 2015; 5(5):1580-93. PubMed ID: 26175929
[TBL] [Abstract][Full Text] [Related]
10. Treatment of glioblastoma multiforme with "classic" 4:1 ketogenic diet total meal replacement.
Klein P; Tyrlikova I; Zuccoli G; Tyrlik A; Maroon JC
Cancer Metab; 2020 Nov; 8(1):24. PubMed ID: 33292598
[TBL] [Abstract][Full Text] [Related]
11. Detection of perillyl alcohol and its metabolite perillic acid in postsurgical glioblastoma tissue after intranasal administration of NEO100: illustrative case.
Schönthal AH; Swenson S; Bonney PA; Wagle N; Simmon VF; Mathew AJ; Hurth KM; Chen TC
J Neurosurg Case Lessons; 2022 Aug; 4(8):. PubMed ID: 36088606
[TBL] [Abstract][Full Text] [Related]
12. The Efficacy of Ketogenic Diet and Associated Hypoglycemia as an Adjuvant Therapy for High-Grade Gliomas: A Review of the Literature.
Varshneya K; Carico C; Ortega A; Patil CG
Cureus; 2015 Feb; 7(2):e251. PubMed ID: 26180675
[TBL] [Abstract][Full Text] [Related]
13. Perillyl alcohol induces apoptosis in human glioblastoma multiforme cells.
Fernandes J; da Fonseca CO; Teixeira A; Gattass CR
Oncol Rep; 2005 May; 13(5):943-7. PubMed ID: 15809762
[TBL] [Abstract][Full Text] [Related]
14. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
[TBL] [Abstract][Full Text] [Related]
15. Intranasal Perillyl Alcohol for Glioma Therapy: Molecular Mechanisms and Clinical Development.
Chen TC; da Fonseca CO; Schönthal AH
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30563210
[TBL] [Abstract][Full Text] [Related]
16. Na/K-ATPase as a target for anticancer drugs: studies with perillyl alcohol.
Garcia DG; de Castro-Faria-Neto HC; da Silva CI; de Souza e Souza KF; Gonçalves-de-Albuquerque CF; Silva AR; de Amorim LM; Freire AS; Santelli RE; Diniz LP; Gomes FC; Faria MV; Burth P
Mol Cancer; 2015 May; 14():105. PubMed ID: 25976744
[TBL] [Abstract][Full Text] [Related]
17. The Monoterpenoid Perillyl Alcohol: Anticancer Agent and Medium to Overcome Biological Barriers.
Chen TC; da Fonseca CO; Levin D; Schönthal AH
Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959448
[TBL] [Abstract][Full Text] [Related]
18. Anti-thrombin as a prognostic biomarker candidate for patients with recurrent glioblastoma multiform under treatment with perillyl alcohol.
Fischer Jde S; Carvalho PC; Neves-Ferreira AG; da Fonseca CO; Perales J; Carvalho Mda G; Domont GB
J Exp Ther Oncol; 2008; 7(4):285-90. PubMed ID: 19227008
[TBL] [Abstract][Full Text] [Related]
19. Changes in cerebral metabolism during ketogenic diet in patients with primary brain tumors:
Artzi M; Liberman G; Vaisman N; Bokstein F; Vitinshtein F; Aizenstein O; Ben Bashat D
J Neurooncol; 2017 Apr; 132(2):267-275. PubMed ID: 28074323
[TBL] [Abstract][Full Text] [Related]
20. Phase I pharmacokinetic trial of perillyl alcohol (NSC 641066) in patients with refractory solid malignancies.
Hudes GR; Szarka CE; Adams A; Ranganathan S; McCauley RA; Weiner LM; Langer CJ; Litwin S; Yeslow G; Halberr T; Qian M; Gallo JM
Clin Cancer Res; 2000 Aug; 6(8):3071-80. PubMed ID: 10955786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
